Doctronic | Series BMar 2026$40M Series ASep 2025$20M | $60M |
| Co-investors: Faraz Fatemi (Lightspeed Venture Partners), Fei-Fei Li (AI4ALL), Scott Belsky (A24) |
Gyde | Series AJan 2026$60M | $60M |
| Co-investors: Ludwig Schulze (Alumni Ventures ), Vaibhav Domkundwar (Better Capital) |
Assort Health | Series BOct 2025$76M | $100M |
| Co-investors: Kristina Shen (Andreessen Horowitz), Galym Imanbayev (Lightspeed Venture Partners), Bill Trenchard (First Round Capital), Matt Humphrey (Quiet Capital) |
Thyme Care | Series DSep 2025$97M Series CJul 2024$55M Series BAug 2023$60M Series AOct 2021$22M | $230M |
| Co-investors: Vineeta Agarwala (Andreessen Horowitz), Faraz Rahman (CVS Health), David Whelan (Town Hall Ventures), Vijay Patel (CVS Health Ventures), Kurt Sheline (Echo Health Ventures), Vivek Garipalli |
Odyssey Therapeutics | Series DSep 2025$210M | $700M |
| Co-investors: Elena Viboch (General Catalyst), Jonathan MacQuitty (Lightspeed Venture Partners), Ravi Mhatre (Lightspeed Venture Partners), Nan Li (Obvious Ventures), Carl Gordon (OrbiMed Advisors), Jill carroll (SR One), Lorence Kim (Third Rock Ventures) |
Tennr | Series CJun 2025$100M | $160M |
| Co-investors: Guru Chahal (Lightspeed Venture Partners), Somesh Dash (IVP), Zeya Yang (Andreessen Horowitz), Galym Imanbayev (Lightspeed Venture Partners), Joanne Chen (Foundation Capital), Jennifer Kaehms (Foundation Capital), Allison Pickens (Allison Pickens Ventures, formerly The New Normal Fund), Warrick Shanly (Soma Capital), Alex Kayyal (Salesforce Ventures) |
Neuralink | Series EMay 2025$650M | $1.2B |
| Co-investors: Peter Thiel (Founders Fund), Michael Mignano (Lightspeed Venture Partners), Shaun Maguire (Sequoia Capital), Andrew Reed (Sequoia Capital), Ravi Mhatre (Lightspeed Venture Partners), Jonathan MacQuitty (Lightspeed Venture Partners), Fred Ehrsam (Paradigm), Krishna Yeshwant (GV (Google Ventures)), David Krane (GV (Google Ventures)), Bryan Rosenblatt (Craft Ventures), Robert Nelsen (ARCH Venture Partners), Bill Lee (Craft Ventures), Blake Byers (NewLimit), Ken Howery (Unknown Ventures), Sam Altman, Shane Neman |
Antares Therapeutics | Series AMay 2025$180M | $180M |
| Co-investors: Jonathan MacQuitty (Lightspeed Venture Partners), Ravi Mhatre (Lightspeed Venture Partners), Jean-François Formela (Atlas Venture) |